Shmuel Ben-Sasson
Inventor
Stats
- 8 US patents issued
- 26 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 8 US Patents Issued
- 26 US Applications Filed
- 98 Total Citation Count
- Nov 1, 2021 Most Recent Filing
- Oct 15, 1985 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| CHILDREN'S MEDICAL CENTER CORPORATION | 4
1 1 1 1 | 2001
2002 2003 2004 2006 |
| CHILDREN'S HOSPITAL, INC. | 1
| 2003
|
| YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM | 3
1 3 2 1 1 2 4 1 | 2001
2002 2003 2004 2006 2011 2012 2014 2017 |
| TILTAN PHARMA LTD. | 1
| 2013
|
| Rafa Laboratories Ltd. | 1
1 | 1985
1987 |
Inventor Addresses
| Address | Duration |
|---|---|
| JERUSALEM, IL | Jul 16, 20 - Jul 16, 20 |
| Jerusalem, IL | Oct 25, 88 - Sep 24, 24 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A01H: | NEW PLANTS OR PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES | 2 |
| A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 1 |
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 21 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 12097179 | 2024 | Carbazole derivatives for the treatment of fibrotic diseases and related symptoms, and conditions thereof | 0 |
| 2023/0338,322 | 2023 | GLYCERYLTRIACETATE (GTA) FOR USE IN IMPROVING BREATHING | 0 |
| 2022/0117,935 | 2022 | CARBAZOLE DERIVATIVES FOR THE TREATMENT OF FIBROTIC DISEASES AND RELATED SYMPTOMS, AND CONDITIONS THEREOF | 0 |
| 2022/0000,805 | 2022 | COMBINATION OF M-OPIOID RECEPTOR (MOR) MODULATORS FOR PREVENTING AND TREATING PAIN, SUICIDALITY AND MENTAL DISORDERS | 0 |
| 11191748 | 2021 | Carbazole derivatives for the treatment of fibrotic diseases and related symptoms, and conditions thereof | 1 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.